Trial Details
COMPLETEDBasic Information
| Clinical ID | c1211 |
|---|---|
| Identifier | NCT03675477 |
| Trial Title | A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: SHR0302|DRUG: Placebo |
Participant Information
| Sponsor | Reistone Biopharma Company Limited |
|---|---|
| City | Lake Wales |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2019-04-13 |
|---|---|
| Primary Completion Date | 2020-11-30 |
| Completion Date | 2021-02-03 |